Galecto, Inc. Common Stock (GLTO) is a publicly traded Healthcare sector company. As of May 21, 2026, GLTO trades at $28.69 with a market cap of $1.73B and a P/E ratio of 5.43. GLTO moved -0.21% today. Year to date, GLTO is +236.34%; over the trailing twelve months it is +606.65%. Its 52-week range spans $2.01 to $38.33. Analyst consensus is buy with an average price target of $43.67. Rallies surfaces GLTO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own GLTO include Orbimed Advisors. The latest tracked quarter is Sep 30, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Galecto, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $28.69 |
| Market Cap | $1.73B |
| P/E Ratio | 5.43 |
| EPS | $5.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $38.33 |
| 52-Week Low | $2.01 |
| Volume | 231.69K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.16M |
| Net Income | $-235.02M |
| Gross Margin | 0.00% |
5 analysts cover GLTO: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $43.67.